UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Site-Specific Polysialylation of an Antitumor Single-Chain Fv Fragment

Bioconjugate chemistry, 2009-05, Vol.20 (5), p.924-931

2009

Volltextzugriff (PDF)

Antibodies targeting cancer stem cells: A new paradigm in immunotherapy?

mAbs, 2009-01, Vol.1 (1), p.12-25

2009

Volltextzugriff (PDF)

Phase III Trial of Intraperitoneal Therapy With Yttrium-90–Labeled HMFG1 Murine Monoclonal Antibody in Patients With Epithelial Ovarian Cancer After a Surgically Defined Complete Remission

Journal of clinical oncology, 2006-02, Vol.24 (4), p.571-578

2006

Volltextzugriff (PDF)

Modulation of Antibody Pharmacokinetics by Chemical Polysialylation

Bioconjugate chemistry, 2008-03, Vol.19 (3), p.643-650

2008

Volltextzugriff (PDF)

Abstract 2987: Generation of a selectively cytotoxic fusion protein against p53 mutated cancers

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.2987-2987

2016

Volltextzugriff (PDF)

Generation of a selectively cytotoxic fusion protein against p53 mutated cancers

BMC cancer, 2012-08, Vol.12 (1), p.338-338, Article 338

2012

Volltextzugriff (PDF)

Antibody directed enzyme prodrug therapy (ADEPT): a review of the experimental and clinical considerations

Anticancer research, 1999-01, Vol.19 (1A), p.605

1999

Volltextzugriff (PDF)

Imaging of metastatic melanoma utilising a technetium-99m labelled RGD-containing synthetic peptide

European journal of nuclear medicine, 1998-10, Vol.25 (10), p.1383-1389

1998

Volltextzugriff (PDF)

The Secret Role of microRNAs in Cancer Stem Cell Development and Potential Therapy: A Notch-Pathway Approach

Frontiers in oncology, 2015-02, Vol.4, p.389-389

2015

Volltextzugriff (PDF)

CAMPATH-1H monoclonal antibody in therapy for previously treated low-grade non-Hodgkin's lymphomas : A phase II multicenter study

Journal of clinical oncology, 1998-10, Vol.16 (10), p.3257-3263

1998

Volltextzugriff (PDF)

Characterisation and internalisation of recombinant humanised HMFG-1 antibodies against MUC1

British journal of cancer, 2005-11, Vol.93 (11), p.1257-1266

2005

Volltextzugriff (PDF)

Exploiting altered glycosylation patterns in cancer: Progress and challenges in diagnosis and therapy

Trends in Biotechnology, 1994-06, Vol.12 (6), p.227-233

1994

Volltextzugriff (PDF)

In vitro cytotoxicity following specific activation of amygdalin by β‐glucosidase conjugated to a bladder cancer‐associated monoclonal antibody

International journal of cancer, 1998-12, Vol.78 (6), p.712-719

1998

Volltextzugriff (PDF)

Long term survival of patients with advanced ovarian cancer treated with intraperitoneal radioimmunotherapy

International journal of gynecological cancer, 2000-01, Vol.10 (S1), p.44-46

2000

Volltextzugriff (PDF)

E‐cadherin expression in bladder cancer using formalin‐fixed, paraffin‐embedded tissues: Correlation with histopathological grade, tumour stage and survival

International journal of cancer, 1995-12, Vol.64 (6), p.367-370

1995

Volltextzugriff (PDF)

Glycoengineering Approach to Half-Life Extension of Recombinant Biotherapeutics

Bioconjugate chemistry, 2012-08, Vol.23 (8), p.1524-1533

2012

Volltextzugriff (PDF)

Adjuvant therapy of ovarian cancer with radioactive monoclonal antibody

British journal of cancer, 1993-08, Vol.68 (2), p.403-406

1993

Volltextzugriff (PDF)

Design, characterization and anti-tumour cytotoxicity of a panel of recombinant, mammalian ribonuclease-based immunotoxins

British journal of cancer, 1998-02, Vol.77 (4), p.537-546

1998

Volltextzugriff (PDF)

Targeting enzymes for cancer therapy: old enzymes in new roles

British journal of cancer, 1994-11, Vol.70 (5), p.786-794

1994

Volltextzugriff (PDF)

AB1, a novel protein targeting TP53 mutated GI tumors

Journal of clinical oncology, 2022-02, Vol.40 (4_suppl), p.96-96

2022

Volltextzugriff (PDF)

Decreased intraperitoneal disease recurrence in epithelial ovarian cancer patients receiving intraperitoneal consolidation treatment with yttrium‐90‐labeled murine HMFG1 without improvement in overall survival

International journal of cancer, 2007-06, Vol.120 (12), p.2710-2714

2007

Volltextzugriff (PDF)

Antibody‐guided enzyme therapy of cancer producing cyanide results in necrosis of targeted cells

International journal of cancer, 2002-05, Vol.99 (1), p.138-148

2002

Volltextzugriff (PDF)

Immune responses in advanced colorectal cancer following repeated intradermal vaccination with the anti-CEA murine monoclonal antibody, PR1A3 : results of a phase I study

International journal of colorectal disease, 2005-09, Vol.20 (5), p.403-414

2005

Volltextzugriff (PDF)

Radioimmunotherapy after chemotherapy compared to chemotherapy alone in the treatment of advanced ovarian cancer: a matched analysis

Oncology reports, 1998-01, Vol.5 (1), p.223

1998

Volltextzugriff (PDF)

Radioimmunoscintigraphy in Patients with Ovarian Cancer

Acta oncologica, 2001, Vol.40 (5), p.549-557

2001

Volltextzugriff (PDF)

1 – 25 von 319

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(279)
Mit Volltextzugriff
(247)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(165)
Life Sciences & Biomedicine
(120)
Science & Technology
(120)
Biological And Medical Sciences
(107)
Female
(94)
Medical Sciences
(94)
Animals
(76)
Oncology
(73)
Mice
(55)
Middle Aged
(53)
Antibodies, Monoclonal - Therapeutic Use
(48)
Male
(46)
Tumors
(46)
Adult
(43)
Aged
(42)
Antibodies, Monoclonal
(38)
Iodine Radioisotopes
(36)
Radionuclide Imaging
(35)
Immunotherapy
(31)
Antibodies, Monoclonal - Immunology
(29)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Site-Specific Polysialylation of an Antitumor Single-Chain Fv Fragment

Antibodies targeting cancer stem cells: A new paradigm in immunotherapy?

Phase III Trial of Intraperitoneal Therapy With Yttrium-90–Labeled HMFG1 Murine Monoclonal Antibody in Patients With Epithelial Ovarian Cancer After a Surgically Defined Complete Remission

Modulation of Antibody Pharmacokinetics by Chemical Polysialylation

Abstract 2987: Generation of a selectively cytotoxic fusion protein against p53 mutated cancers

Generation of a selectively cytotoxic fusion protein against p53 mutated cancers

Antibody directed enzyme prodrug therapy (ADEPT): a review of the experimental and clinical considerations

Imaging of metastatic melanoma utilising a technetium-99m labelled RGD-containing synthetic peptide

The Secret Role of microRNAs in Cancer Stem Cell Development and Potential Therapy: A Notch-Pathway Approach

CAMPATH-1H monoclonal antibody in therapy for previously treated low-grade non-Hodgkin's lymphomas : A phase II multicenter study

Characterisation and internalisation of recombinant humanised HMFG-1 antibodies against MUC1

Exploiting altered glycosylation patterns in cancer: Progress and challenges in diagnosis and therapy

In vitro cytotoxicity following specific activation of amygdalin by β‐glucosidase conjugated to a bladder cancer‐associated monoclonal antibody

Long term survival of patients with advanced ovarian cancer treated with intraperitoneal radioimmunotherapy

E‐cadherin expression in bladder cancer using formalin‐fixed, paraffin‐embedded tissues: Correlation with histopathological grade, tumour stage and survival

Glycoengineering Approach to Half-Life Extension of Recombinant Biotherapeutics

Adjuvant therapy of ovarian cancer with radioactive monoclonal antibody

Design, characterization and anti-tumour cytotoxicity of a panel of recombinant, mammalian ribonuclease-based immunotoxins

Targeting enzymes for cancer therapy: old enzymes in new roles

AB1, a novel protein targeting TP53 mutated GI tumors

Decreased intraperitoneal disease recurrence in epithelial ovarian cancer patients receiving intraperitoneal consolidation treatment with yttrium‐90‐labeled murine HMFG1 without improvement in overall survival

Antibody‐guided enzyme therapy of cancer producing cyanide results in necrosis of targeted cells

Immune responses in advanced colorectal cancer following repeated intradermal vaccination with the anti-CEA murine monoclonal antibody, PR1A3 : results of a phase I study

Radioimmunotherapy after chemotherapy compared to chemotherapy alone in the treatment of advanced ovarian cancer: a matched analysis

Radioimmunoscintigraphy in Patients with Ovarian Cancer

Suchergebnisse filtern